Trial intelligence / Profile preview

Post-marketing surveillance of Tarlige tablets in peripheral neuropathic pain

jRCT2031200212Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of mirogabalin in Peripheral neuropathic pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Incidence of onset of diabetes mellitus, Incidence of aggravated diabetes mellitus and 1 more. Started Oct 2020; status: completed.

02

Drugs

mirogabalin
03

Conditions

Peripheral neuropathic pain

Beyond the preview

Go deeper on jRCT2031200212.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2031200212.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call